Abstract:Background Heavy menstrual bleeding (HMB) is one of the most common gynecologic disorders among adolescents. While anovulatory bleeding (AB) is usually the underlying cause, a previously undiagnosed bleeding disorder (BD) can also may also lead to such bleeding. It has been reported that approximately 20% of adolescents with HMB and up to 33% of girls hospitalized for HMB may have BD. The aim of our study was to investigate the prevalence of BD in a population of adolescents who were evaluated for HMB and whose hemoglobin values were 12 and below Methods We retrospectively reviewed medical records of 137 adolescents aged 10 to 18 years who were presented with HMB to a tertiary Pediatric and Adolescent Gynecology Service between July 2017 and September 2023 and had hemoglobin values of 12 g/dL and below. Data on medical history, menstrual history, bleeding symptoms, gynecologic evaluation, hospitalization, blood transfusion, treatments, and screening for BD were evaluated. Results A total of 137 adolescents with HMB met the inclusion criteria. The mean age at the onset of symptoms and at menarche 14±1.9 years and 12.1±1.3 years, respectively. A history of previously diagnosed BD or a medical condition that could cause BD was identified in 14 patients. The mean hemoglobin value on presentation was 8.1±2.2 g/dL. The rate of hospitalization for management was 51% (70/137) and 44 patients (32.1%) received packed red blood cell transfusions. Evaluation for the presence of a bleeding disorder was performed in 106/123 (%86.1) of the patients. Overall, 9 adolescents were diagnosed with some underlying BD, giving a prevalence of 9/106 (8.4%) in those screened for BD (Table 1). Among these 9 patients, von Willebrand disease was the most common BD (55%). When all patients are divided into two groups as those with an initial Hb value of 8 or less (Group 1) and those with a Hb value between 8 and 12 (Group 2), 5.5% of patients in Group 1 (3/55) and 11.7% in Group 2 (6/51) had a coagulation disorders, with no statistically significant difference (Table 2). Conclusions In this age group, anovulatory bleeding alone may cause severe anemia required inpatient hospital stays and blood transfusion needs. Timely initiation of hormonal suppression in these cases is important to reduce these negative consequences. According to our findings, the rate of detection of BD was 8.4% in the adolescents presented with HMB. The fact that the detection rate of BD was found to be higher in adolescents who presented with a more chronic bleeding complaint and mild anemia suggested that BD screening should be performed with the same care in this group.

Systematic review and meta-analysis of the etiology of heavy menstrual bleeding in 2,770 adolescent females

108. Prevalence of bleeding disorders in adolescents presenting with heavy menstrual bleeding and anemia

Assessment of rare bleeding disorders in adolescents with heavy menstrual bleeding

Abnormal Uterine Bleeding in Premenopausal Women

109. Primary Care Referrals for Heavy Menstrual Bleeding in Adolescents: A Retrospective Chart Review

Treatment Modalities in Adolescents Who Present with Heavy Menstrual Bleeding

Clinical Perspectives on the Menstrual Pictogram for the Assessment of Heavy Menstrual Bleeding

Assessment of Iron Status in Adolescents Presenting to the Emergency Department With Heavy Menstrual Bleeding

Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic

Abnormal Uterine Bleeding including coagulopathies and other menstrual disorders

Adolescent menstrual disorders

Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2

Knowledge and Confidence of Obstetrics and Gynecology Residents in the Evaluation and Management of Heavy Menstrual Bleeding Due to Inherited Bleeding Disorders

Menorrhagia: an update

Diagnosis and management of abnormal uterine bleeding in adolescence

Heavy menstrual bleeding, iron deficiency, and iron deficiency anemia: Framing the issue

Menstrual Disorders in Adolescence: Pathophysiology and Treatment

Recent advances in managing and understanding menstrual disorders

Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding

Uterine disorders and iron deficiency anemia

Prospective evaluation of ISTH‐BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic